Aspin Pharma

What Aspin Pharma does

Aspin Pharma Pvt. Ltd. is a privately held Pakistani pharmaceutical manufacturer and subsidiary of the OBS Group conglomerate, headquartered at the Korangi Industrial Area in Karachi. The company develops, manufactures, and markets a broad branded-generic portfolio spanning antibiotics (M-Span, Aspimox), proton pump inhibitors (Kapdex), oral anti-diabetics (Jantovia-M XR), anti-anginals (Ikodil), anti-diarrheals (Imodium), anti-emetics (Ondaset), sex hormones (Testiva), anti-acne/PCOS (Colicare), and nutritional supplements (Iroxide-F). Technical operations include in-house Manufacturing, Research & Development, Supply Chain Management, and Environment, Health & Safety (EHS) functions.

The company generates revenue through prescription pharmaceutical sales distributed via a domestic pharmacy network and direct supply to hospitals and healthcare institutions in Pakistan, with pricing subject to regulatory oversight. Product launches have been sustained across 2020–2023 (Amlowell, Ondaset, Testiva, Aspracin, Colicare, Aspimox, Iroxide-F), and the company launched an International Business page signaling nascent export interest. Corporate positioning is reinforced through the 'Aspin Cares' health-awareness sub-brand and CSR activities such as the Breast Cancer Awareness Campaign at Governor House Sindh.

Aspin Pharma operates within the broader OBS Group, which also encompasses AGP Limited (a sister/affiliated entity) and OBS-AGP — a vehicle used to acquire selected portfolio assets from Sandoz Pakistan, evidencing inorganic consolidation activity. Leadership disclosed in the data is limited to Simon Francis (COO). The company is not publicly listed, has no disclosed funding rounds or revenue figures, and has 501–1,000 employees. No AI/ML, digital health platform, or proprietary software products are evidenced.

Name

Aspin Pharma

Legal name

Aspin Pharma Pvt. Ltd.

Website

https://aspin.com.pk

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Aspin Pharma is a Karachi-based, OBS Group-affiliated pharmaceutical manufacturer that produces and sells branded generic prescription medicines across antibiotics, cardiovascular, anti-diabetic, gastrointestinal, and nutritional therapeutic categories to healthcare providers and patients in Pakistan.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Oral Solid Dose (OSD) Generics (HLAIABAD), Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG)

Keywords

• Pharmaceutical manufacturing
• Prescription medicines
• Generic pharmaceuticals
• Anti-infective drugs
• Cardiology medications

Headquarters

HQ city

Karachi

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Aspin Pharma generates revenue through the sale of branded generic pharmaceutical products across multiple therapeutic categories including analgesics, antibiotics, anti-diabetics, cardiovascular drugs, and nutritional supplements, sold via prescription through pharmacies in Pakistan.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Aspin Pharma manufactures and markets branded generic prescription pharmaceutical products across multiple therapeutic categories including antibiotics, anti-diabetics, cardiovascular drugs, proton pump inhibitors, anti-diarrheals, anti-emetics, nutritional supplements, and sex hormone therapies. Products are produced through in-house formulation and manufacturing operations and sold to pharmacies, hospitals, and healthcare institutions across Pakistan under the OBS Group umbrella.

Product overview

Aspin Pharma is a pharmaceutical company that offers a portfolio of prescription and over-the-counter medications across multiple therapeutic categories. The product portfolio includes antibiotics (M-Span, Aspimox), cardiovascular medications (Jantovia-M XR, Ikodil), gastrointestinal treatments (Kapdex, Imodium, Ondaset), nutritional supplements (Iroxide-F), and specialty products (Testiva, Colicare, Amlowell, Aspracin). The company operates under the OBS Group and focuses on providing quality medicines. Products are distributed in Pakistan with a presence across various therapeutic areas including Analgesics, Anti Biotics, Anti Depressants, Anti Epileptics, Anti Gout, Anti Hypertensives, Anti Obesity, Anti Ulcerants, Anti Vertigo, Anti-bacterials, Anti-diarrheals, Anti-fungals, Anti-Lipidemics, Antivirals, Beta Blockers, Cardiology, Cough suppressants, Gastroprokinetics, Hepatitis B and C treatments, Neurology, Nutraceuticals, Oral Anti Diabetics, Proton Pump Inhibitors, Sex Hormones, Topical Anti-Septics, and Urologicals.

Differentiator

Problem solved

Functional benefit

Brands

• Aspin Cares: Health awareness initiative by Aspin Pharma focused on public health campaigns and community health education.

Products and services

• Iroxide-F Iron (III) Hydroxide Polymaltose Complex (IPC) 100mg + Folic Acid (FA) 0.35mg nutritional supplement for iron deficiency treatment, distributed as a prescription medicine in Pakistan.
• Jantovia-M XR Sitagliptin and Metformin HCl extended release tablets; oral antidiabetic medication for glycemic control in adults with type 2 diabetes mellitus, dispensed via prescription across Pakistan.
• Kapdex Dexlansoprazole 30mg and 60mg capsules; proton pump inhibitor (PPI) for treatment of erosive esophagitis and gastro-oesophageal reflux disease (GERD).
• Imodium Loperamide hydrochloride 2mg capsules; anti-propulsive anti-diarrheal agent used in the treatment of diarrhea.
• Ikodil Nicorandil 10mg and 20mg tablets; oral anti-anginal medication for patients with chronic angina.
• M-Span Cefixime 400mg capsules and suspensions (100mg/5ml and 200mg/5ml DS); antibiotic used for treatment of bacterial infections.
• Aspracin Pharmaceutical product positioned by Aspin Pharma as meeting international quality standards, serving patients and healthcare providers in Pakistan.
• Ondaset Anti-emetic and antinauseant medication for nausea treatment.
• Testiva Sex hormone medication for patient care.
• Aspimox Antibiotic medication distributed through Pakistani pharmacies.
• Amlowell Pharmaceutical product in Aspin Pharma's branded generic portfolio, sold via prescription through Pakistani pharmacies.
• Colicare Product for Anti Acne treatment and PCOS management, sold through Pakistani pharmacies.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• OBS GroupcoreStrategic or Co-development PartnerAspin Pharma is a part of the OBS Group of companies, one of Pakistan's pharmaceutical groups. The group operates manufacturing and distribution facilities and includes entities like AGP Limited.
• AGP LimitedcoreStrategic or Co-development PartnerAGP Limited is a related pharmaceutical company within the OBS Group, with its headquarters at B-23-C, S.I.T.E., Karachi. Both companies operate under the same corporate umbrella.
• Sandoz PakistanminorOthersOBS-AGP was set up to acquire selected portfolio from Sandoz Pakistan, as part of business acquisition activities within the OBS Group.

Scale indicators1 record

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• Sanofi Pakistan: Multinational pharmaceutical player active in Pakistan across cardiometabolic, vaccines, and consumer health; competes with Aspin on branded established molecules with deeper marketing budgets.
• Bayer Pakistan: Multinational with presence in Pakistan pharmaceuticals and consumer health; competes with Aspin in cardiovascular, GI, and selected primary-care categories via larger scale and global brand equity.
• GSK Pakistan: Multinational pharmaceutical company operating across antibiotics, vaccines, and consumer health in Pakistan; one of the largest players, sets the competitive context for Aspin's anti-infective and primary-care portfolio.
• Abbott Pakistan: Multinational incumbent in Pakistan pharma covering prescription generics, nutrition, and diagnostics; competes directly with Aspin's chronic-care portfolio through a much larger commercial and manufacturing footprint.

Direct peers

• Ferozsons Laboratories: Established Pakistan pharmaceutical company covering branded generics, biologicals, and licensing arrangements with multinational pharma; comparable scale, therapeutic breadth, and Pakistan-only footprint.
• AGP Limited: Sister/affiliated pharmaceutical company operating under OBS Group in Pakistan; directly comparable business model, geographic footprint, and product portfolio across branded generics, antibiotics, and chronic-care therapies.
• Searle Pakistan: Pakistan-listed pharmaceutical manufacturer with a broad branded-generic portfolio across chronic and acute therapy areas; comparable go-to-market through medical representatives and pharmacy distribution.
• Getz Pharma: One of Pakistan's largest branded-generic pharmaceutical manufacturers; directly overlaps Aspin in therapeutic categories (cardio, anti-infectives, GI, nutrition) with a comparable hospital-and-pharmacy distribution model.
• Hilton Pharma: Pakistan-focused pharmaceutical manufacturer with a multi-therapeutic branded-generic portfolio spanning gastroenterology, cardiology, anti-infectives, and nutrition; competes for the same prescriber and pharmacy channel.

Regional players

• Sandoz (Novartis): Global generics leader whose selected Pakistan portfolio was acquired by OBS-AGP (Aspin Pharma's sister vehicle); defines the source of Aspin's inherited product brands and the multinational generic competitive benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/AspinCaresOfficial
• LinkedInlinkedin.com/company/aspin-pharma-pvt-ltd
• Instagraminstagram.com/aspincares

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspin Pharma